Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. Friday, Nov. 8, 2013, 143 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $296.78 to $400,200,000.00. Highlighted Stocks Traded by Insiders: DaVita HealthCare Partners (DVA) - FREE Research Report Berkshire Hathaway Inc who is 10% Owner at DaVita HealthCare Partners bought 3.7 million shares at $55.14 on Nov. 8, 2013. Following this transaction, the 10% Owner owned 35.1 million shares meaning that the stake was reduced by 11.77% with the 3.7 million share transaction. Weschler, R. Ted who is Member of 10% owner group at DaVita HealthCare Partners bought 3.7 million shares at $55.14 on Nov. 8, 2013. Following this transaction, the Member of 10% owner group owned 35.1 million shares meaning that the stake was reduced by 11.77% with the 3.7 million share transaction. The shares most recently traded at $56.88, up $1.74, or 3.05% since the insider transaction. The average volume for DaVita HealthCare Partners has been 1.4 million shares per day over the past 30 days. Shares are up 0.9% year to date as of the close of trading on Friday. DaVita HealthCare Partners Inc. provides kidney dialysis services for patients suffering from chronic kidney failure, or end stage renal disease (ESRD) in the United States. The company has a P/E ratio of 20.5. Currently there are 7 analysts that rate DaVita HealthCare Partners a buy, no analysts rate it a sell, and 5 rate it a hold. Exclusive Offer: Get the latest Stock Analysis on DVA - FREE TheStreet Quant Ratings rates DaVita HealthCare Partners as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations and reasonable valuation levels. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full DaVita HealthCare Partners Ratings Report from TheStreet Quant Ratings now. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.